NCEP:ATPIIIa 2001 and Harmonizing Definition Criteria for the Metabolic Syndrome

NCEP:ATPIII 2001	HARMONIZING DEFINITION^b
NCEP:ATPIII^a 2001 and Harmonizing Definition Criteria for the Metabolic Syndrome
Three or more of the following: Central obesity: waist circumference >102 cm (M), >88 cm (F) Hypertriglyceridemia: triglyceride level ≥150 mg/dL or specific medication Low HDL^c cholesterol: <40 mg/dL and <50 mg/dL for men and women, respectively, or specific medication Hypertension: blood pressure ≥130 mmHg systolic or ≥85 mmHg diastolic or specific medication Fasting plasma glucose level ≥100 mg/dL or specific medication or previously diagnosed type 2 diabetes	Three of the following: Waist circumference (cm)
	Men	Women	Ethnicity
	≥94	≥80	Europid, sub-Saharan African, Eastern and Middle Eastern
	≥90	≥80	South Asian, Chinese, and ethnic South and Central American
	≥85	≥90	Japanese
	Fasting triglyceride level >150 mg/dL or specific medication HDL cholesterol level <40 mg/dL and <50 mg/dL for men and women, respectively, or specific medication Blood pressure >130 mm systolic or >85 mm diastolic or previous diagnosis or specific medication Fasting plasma glucose level ≥100 mg/dL (alternative indication: drug treatment of elevated glucose levels)

^a National Cholesterol Education Program and Adult Treatment Panel III.

^b In this analysis, the following thresholds for waist circumference were used: white men, ≥94 cm; African-American men, ≥94 cm; Mexican-American men, ≥90 cm; white women, ≥80 cm; African-American women, ≥80 cm; Mexican-American women, ≥80 cm. For participants whose designation was “other race-including multiracial,” thresholds that were once based on Europid cutoffs (≥94 cm for men and ≥80 cm for women) and on South Asian cutoffs (≥90 cm for men and ≥80 cm for women) were used. For participants who were considered “other Hispanic,” the International Diabetes Federation thresholds for ethnic South and Central Americans were used.

^c High-density lipoprotein.

section name header

Table 120-1